Background Coronavirus disease 2019 (COVID-19) has become a global pandemic,
affecting millions of people. However, the relationship between COVID-19 and acute …

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic spreads, it
is becoming increasingly evident that coronavirus disease 2019 (COVID-19) is not limited to …

Evidence from previous coronavirus outbreaks has shown that infected patients are at risk
for developing psychiatric and mental health disorders, such as depression, anxiety, and …

Objectives/Hypothesis Olfactory dysfunction has been observed as one of the clinical
manifestations in COVID‐19 patients. We aimed to conduct a systematic review and meta …

Abstract Introduction Coronavirus disease-19 (COVID-19) pandemic continues to grow all
over the world. Several studies have been performed, focusing on understanding the acute …

Objectives: Extensive studies indicate that severe acute respiratory syndrome coronavirus
(SARS-CoV-2) involves human sensory systems. A lack of discussion, however, exists given …

A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …

There is accumulating evidence of the neurological and neuropsychiatric features of
infection with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to …

This is the first update of the previously published living systematic review that summarized
evidence on the prevalence of oral signs and symptoms in patients with COVID-19. Hitherto …

Survivors to COVID-19 have described long-term symptoms after acute disease. These
signs constitute a heterogeneous group named long COVID or persistent COVID. The aim of …